World's Best Scientists 2026 revealed!
Peter E. Schwartz

Peter E. Schwartz

D-Index & Metrics

Medicine

D-Index
87
Citations
26043
World Ranking
13713
National Ranking
6963

Overview

Peter E. Schwartz is affiliated with Yale University in the United States. Their research is primarily situated in the field of Medicine, with a significant focus on Oncology and related subfields such as Reproductive Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

The scientist's research topics cover a range of subjects concentrated on cancer diagnosis and treatment, including:

  • Ovarian cancer diagnosis and treatment
  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Sarcoma Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Intraperitoneal and Appendiceal Malignancies
  • Cell Adhesion Molecules Research

Recent papers authored or co-authored by Peter E. Schwartz include:

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis, 2020, Clinical Cancer Research
  • Integrated mutational landscape analysis of uterine leiomyosarcomas, 2021, Proceedings of the National Academy of Sciences
  • A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability, 2021, Cancer
  • Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan, 2020, Scientific Reports
  • Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer, 2020, Frontiers in Oncology

Frequent co-authors collaborating with Peter E. Schwartz include:

  • Elena Ratner
  • Alessandro D. Santin
  • Masoud Azodi
  • Gary Altwerger
  • Stefania Bellone

The scientist's work appears in a variety of publication venues, with multiple publications in:

  • Gynecologic Oncology
  • Clinical Cancer Research
  • Proceedings of the National Academy of Sciences
  • Journal of Clinical Oncology
  • British Journal of Cancer

Best Publications

  • Serum protein markers for early detection of ovarian cancer

    Gil Mor;Irene Visintin;Yinglei Lai;Hongyu Zhao

  • Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

    Ayesha B. Alvero;Rui Chen;Han-Hsuan Fu;Michele Montagna

  • Diagnostic Markers for Early Detection of Ovarian Cancer

    Irene Visintin;Ziding Feng;Gary Longton;David C. Ward

  • High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

    Urania Magriples;Frederick Naftolin;Peter E. Schwartz;Maria Luisa Carcangiu

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

    Roxana Moslehi;Roxana Moslehi;William Chu;Beth Karlan;David Fishman

  • Psychosocial benefits of a cancer support group.

    Eileen N. Cain;Ernest I. Kohorn;Donald M. Quinlan;Kate Latimer

  • Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells

    R Chen;A B Alvero;D A Silasi;M G Kelly

  • A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM

    Jennwer L. Kelsey;Virginia A. Livolsi;Theodore R Holford;Diana B. Fischer

  • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.

    B E Nelson;A T Rosenfield;P E Schwartz

  • AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY

    Nancy G. Hildreth;Jennifer L. Kelsey;Virginia A. Livolsi;Diana B. Fischer

  • Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

    Siming Zhao;Murim Choi;John D. Overton;Stefania Bellone

  • Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

    Mary Carrington;Sophia Wang;Maureen P. Martin;Xiaojiang Gao

  • Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.

    Jacob Tangir;Daniel Zelterman;Wenging Ma;Peter E Schwartz

  • Low-grade endometrial stromal sarcoma: hormonal aspects☆

    Micheline C Chu;Gil Mor;Chungyun Lim;Wenxin Zheng

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Antonis C. Antoniou;Jonathan Beesley;Lesley McGuffog;Olga M. Sinilnikova

  • Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

    June Y. Hou;Michael G. Kelly;Herbert Yu;Jessica N. McAlpine

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

    Wenxin Zheng;Xiaofang Yi;Oluwole Fadare;Oluwole Fadare;Sharon X. Liang

  • Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

    Michael G. Kelly;David M. O'malley;Pei Hui;Jessica Mcalpine

Frequent Co-Authors

Alessandro D. Santin
Alessandro D. Santin Yale University
Sergio Pecorelli
Sergio Pecorelli University of Brescia
Gil Mor
Gil Mor Wayne State University
Lingeng Lu
Lingeng Lu Yale University
Neil J. MacLusky
Neil J. MacLusky University of Guelph
Cary P. Gross
Cary P. Gross Yale University
Melinda L. Irwin
Melinda L. Irwin Yale University
Harvey A. Risch
Harvey A. Risch Yale University
Jason D. Wright
Jason D. Wright Columbia University
Virginia A. LiVolsi
Virginia A. LiVolsi University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open up rewarding career opportunities for those interested in medicine, but looking for flexible or accessible online routes. For students who want to enter the field quickly, there are easy nursing programs to get into that offer a streamlined admission process, helping aspiring nurses start their education without lengthy waiting periods.

Some students may be concerned about standardized testing. Fortunately, there are nursing school that don't require teas or other entrance exams, making the application process more accessible.

If you’re interested in administration or working behind the scenes, earning a health administration degree online may be the right choice. These programs prepare students for management roles in hospitals, clinics, and other healthcare settings.

For those drawn to healthcare but not direct patient care, consider exploring medical billing and coding schools online. This field is vital for the smooth operation of healthcare facilities and offers strong career prospects—all from a remote or flexible learning environment.

Best Scientists Citing Peter E. Schwartz

Trending Scientists

Recently Published Articles